Cibus, Inc. Logo

Cibus, Inc.

Develops & licenses gene-edited, non-transgenic traits to the seed industry for resilient crops.

CBUS | US

Overview

Corporate Details

ISIN(s):
US13173L1070 (+1 more)
LEI:
Country:
United States of America
Address:
6455 NANCY RIDGE DRIVE, 92121 SAN DIEGO
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Cibus, Inc. is an agricultural biotechnology company that develops and licenses plant traits to the seed industry. The company utilizes a proprietary, high-throughput precision gene-editing technology to create specific, value-added traits in a non-transgenic manner, significantly accelerating the development timeline compared to traditional breeding. Cibus focuses on creating more resilient and sustainable crops by developing traits that provide herbicide tolerance, disease resistance, and pest resistance. Its business model involves partnering with seed companies to integrate these traits into major crops like canola, soybean, and wheat, generating revenue through licensing agreements and royalties.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cibus, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cibus, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cibus, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GeneOne Life Science, Inc. Logo
Develops nucleic acid vaccines & therapies for infectious diseases, cancer & autoimmune disorders.
South Korea
011000
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland
GEM
GENFIT Logo
Biopharma developing therapies & diagnostics for rare, life-threatening liver diseases.
France
GNFT
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom
GENF
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom
GENI
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea
389030
Genomed Spolka Akcyjna Logo
Offers molecular diagnostics and DNA sequencing for medical and scientific research markets.
Poland
GEN
Develops molecular diagnostics using DNA methylation biomarkers for early cancer detection.
South Korea
228760
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France
GV
genOway Logo
Develops custom genetically modified preclinical models for biopharma and academic research.
France
ALGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.